Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Simris Alg ABFRA:5LU -15.15%19 Forward Dividend Yield % is 0.00% as of Jul. 21, 2026. GuruFocus rates FRA:5LU with a GF Score™ of 19/100. The stock has 6 warning signs investors should review. Among 149 Biotechnology companies, Simris Alg AB ranks worse than 671140.27% on this metric.
As of today (2026-07-21), the Forward Annual Dividend Yield of Simris Alg AB is 0.00%.
As of today (2026-07-21), the Trailing Annual Dividend Yield of Simris Alg AB is 0.00%.
FRA:5LU's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.36 * Ranked among companies with meaningful Forward Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Simris Alg AB (FRA:5LU) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Simris Alg AB Forward Dividend Yield % Related Terms
FRA:5LU vs VRTX, REGN, ALNY: Forward Dividend Yield % Comparison
For the Biotechnology subindustry, Simris Alg AB's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Simris Alg AB Forward Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Simris Alg AB's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Simris Alg AB's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Simris Alg AB (FRA:5LU) has a Forward Dividend Yield % of 0.00% as of Jul. 21, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Simris Alg AB and its competitors. According to the industry distribution chart, Simris Alg AB ranks #999999 out of 149 companies in the Biotechnology industry.
Is Simris Alg AB's Forward Dividend Yield % too high?
Simris Alg AB's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Simris Alg AB ranks #999999 out of 149 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Simris Alg AB has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Simris Alg AB's Forward Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Simris Alg AB ranks #999999 out of 149 companies for Forward Dividend Yield %. This places Simris Alg AB in the lower half of its industry. The industry median Forward Dividend Yield % is 1.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.36, based on 149 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Simris Alg AB and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Simris Alg AB's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simris Alg AB stock overvalued right now?
Simris Alg AB (FRA:5LU) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Simris Alg AB's overall GF Score™ is 19/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Simris Alg AB (FRA:5LU), the current Forward Dividend Yield % is 0.00% as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Simris Alg AB is a biotechnology company, engaged in research, development and production of bioactive substances from microalgae, for nutraceutical, cosmeceutical and pharmaceutical applications. The company's technology provides access to bioactive substances with novel functions, while replacing unsustainable raw materials from endangered marine species and ecosystems. Its first commercialised range is a series of omega-3 health supplements marketed under the company's own brand.
19GF Score
Get the complete analysis for FRA:5LU
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5LU has been successfully added to your 
